Q1 2025 · 13F-HR
ACUTA CAPITAL PARTNERS, LLCholdings as filed
Filed 2025-05-15 · accession 0001104659-25-048878
$86.2M
Reported value
34
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $8.9M | 10.4% | 1,219,724 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $8.1M | 9.38% | 106,074 | Common | SOLE |
| 89157D105 | TRML | TOURMALINE BIO INC | $6.5M | 7.53% | 426,882 | Common | SOLE |
| 00032Q104 | WHWK | WHITEHAWK THERAPEUTICS INC | $6.1M | 7.04% | 3,410,402 | Common | SOLE |
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $5.2M | 6.05% | 265,269 | Common | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $4.9M | 5.73% | 785,961 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $4.8M | 5.56% | 67,136 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $4.2M | 4.82% | 7,023 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHA-ADR | $3.6M | 4.22% | 23,340 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $3.3M | 3.83% | 87,141 | Common | SOLE |
| 171757206 | CDTX | CIDARA THERAPEUTICS INC | $2.7M | 3.14% | 125,708 | Common | SOLE |
| H5870P102 | OCS | OCULIS HOLDING AG | $2.4M | 2.76% | 125,000 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $2.4M | 2.73% | 66,662 | Common | SOLE |
| 53635D202 | LQDA | LIQUIDIA CORPORATION | $2.3M | 2.63% | 153,482 | Common | SOLE |
| 10919W405 | DRUG | BRIGHT MINDS BIOSCIENCES INC | $2.2M | 2.50% | 59,748 | Common | SOLE |
| G4444H101 | BBOT | HELIX ACQUISITION CORP II | $2.1M | 2.45% | 187,257 | Common | SOLE |
| 58933Y105 | MRK | MERCK & CO | $2.1M | 2.39% | 22,994 | Common | SOLE |
| 86889P208 | SRZN | SURROZEN INC | $2.0M | 2.30% | 170,000 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $1.9M | 2.18% | 85,454 | Common | SOLE |
| 589492107 | MREO | MEREO BIOPHARMA GROUP PL-ADR | $1.8M | 2.07% | 791,815 | Common | SOLE |
| 90466Y103 | — | UNICYCIVE THERAPEUTICS INC | $1.4M | 1.57% | 2,352,887 | Common | SOLE |
| G50871105 | JAZZ | JAZZ PHARMACEUTICALS PLC | $1.2M | 1.38% | 9,575 | Common | SOLE |
| 92337C203 | VSTM | VERASTEM INC | $1.1M | 1.23% | 176,000 | Common | SOLE |
| 375558103 | GILD | GILEAD SCIENCES INC | $1.0M | 1.21% | 9,298 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $898,518 | 1.04% | 325,550 | Common | SOLE |
| 98985Y108 | ZYME | ZYMEWORKS INC | $815,347 | 0.95% | 68,459 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL INC | $770,911 | 0.89% | 21,290 | Common | SOLE |
| 92539P101 | — | VERVE THERAPEUTICS INC | $743,649 | 0.86% | 162,724 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $555,945 | 0.64% | 83,350 | Common | SOLE |
| 75383L102 | RAPP | RAPPORT THERAPEUTICS INC | $164,492 | 0.19% | 16,400 | Common | SOLE |
| 34962G208 | FBRX | FORTE BIOSCIENCES INC | $143,319 | 0.17% | 18,469 | Common | SOLE |
| 04317A107 | ARTV | ARTIVA BIOTHERAPEUTICS INC | $136,368 | 0.16% | 45,456 | Common | SOLE |
| 67080N119 | NUVB/WS | NUVATION BIO INC -CW27 | $17,494 | 0.02% | 90,832 | Common | SOLE |
| 452CVR012 | — | ENLIVEN THERAPEUTICS INC | $0 | — | 115,805 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.